title: [Aids and anesthesia]  .
abstract: 17 years after the discovery of HIV Aids remains an ultimately fatal disease. Currently no vaccine is available. The worldwide incidence of HIV-infections and Aids associated mortality are rising. Only in Western Europe and in the USA are incidence and mortality of Aids declining; mainly as a result of effective antiretroviral therapy. 20% to 25% of HIV-infected patients require surgery during their illness. The challenges for the anaesthesiologist are possible dysfunction of all important organs and adverse interactions between antiretroviral drugs and anaesthetic agents. If adequate infection control measures are taken the risk of occupational HIV-infection is low, but remains a concern in light of the consequences. Seroconversion after needlestick injury is ca. 0.3%, after contact with mucosa ca. 0.03%.
authors.affiliation: Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Johann Wolfgang Goethe-Universität, Frankfurt.
authors.forename: A
authors.initials: A
authors.lastname: Eichler
authors.forename: U
authors.initials: U
authors.lastname: Eiden
authors.forename: P
authors.initials: P
authors.lastname: Kessler
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000453:epidemiology / Q000401:mortality / Q000635:transmission; D000758:Anesthesia / Q000009:adverse effects*; D019380:Anti-HIV Agents / Q000009:adverse effects; D004347:Drug Interactions; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional
chemical_list: D019380:Anti-HIV Agents
vernacular_title: Aids und Anästhesie.